Literature DB >> 16105367

Temporal change in the prevalence of respiratory symptoms and obstructive airways disease 1993-2001.

Peter I Frank1, Paul D Wicks, Michelle L Hazell, Mary F Linehan, Sybil Hirsch, Philip C Hannaford, Timothy L Frank.   

Abstract

BACKGROUND: There has been little available information regarding secular changes in the prevalence of respiratory symptoms since the mid-1990s. AIM: To examine changes in the prevalence of respiratory symptoms for 1993-2001. DESIGN OF STUDY: A series of postal questionnaire surveys.
SETTING: Two general practice populations, including all age groups.
METHOD: Four postal respiratory questionnaire surveys were conducted between 1993 and 2001. Subjects who replied to two or more surveys (8058 adults and 2350 children) were included in the main analyses. Validated scoring systems were used to define obstructive airways disease in adults and asthma in children.
RESULTS: Over the 8-year observation period there were increases among adults in the crude prevalence of wheeze, being woken by cough, receipt of current asthma medication, and of obstructive airways disease, compared with decreases in children for wheeze, night cough, asthma attacks, and asthma. For adults, adjusted odds ratios per year of secular increase were 1.03 (95% confidence interval [CI] = 1.02 to 1.03) for wheeze, 1.03 (95% CI = 1.02 to 1.03) for being woken by cough, 1.03 (95% CI = 1.02 to 1.04) for asthma medication, and 1.02 (95% CI = 1.01 to 1.03) for obstructive airways disease. These increases were greater in those aged over 44 years, in males, and in those without a family history of asthma or a history of hayfever or eczema. Corresponding decreases for children were 0.94 (95% CI = 0.92 to 0.97) for wheeze, 0.93 (95% CI = 0.91 to 0.96) for night cough, 0.93 (95% CI = 0.90 to 0.95) for asthma attacks and 0.98 (95% CI = 0.95 to 1.00) for asthma.
CONCLUSION: The increases found in adults are more likely to be due to chronic obstructive pulmonary disease (COPD) than asthma. This is supported by the decreases in symptom and asthma prevalence in children.

Entities:  

Mesh:

Year:  2005        PMID: 16105367      PMCID: PMC1463220     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  33 in total

1.  Continued increase in the prevalence of asthma and atopy.

Authors:  S H Downs; G B Marks; R Sporik; E G Belosouva; N G Car; J K Peat
Journal:  Arch Dis Child       Date:  2001-01       Impact factor: 3.791

2.  Assessment of a simple scoring system applied to a screening questionnaire of asthma in children aged 5-15 yrs.

Authors:  T L Frank; P I Frank; R McNamee; T Wright; P Hannaford; J Morrison; S Hirsch; C A Pickering
Journal:  Eur Respir J       Date:  1999-11       Impact factor: 16.671

3.  Increase in prevalence and severity of asthma in young adults in Copenhagen.

Authors:  E F Hansen; Y Rappeport; J Vestbo; P Lange
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

4.  Comparison of reported prevalences of recent asthma in longitudinal and cross-sectional studies.

Authors:  M R Sears; S Lewis; G P Herbison; B Robson; E M Flannery; M D Holdaway; N Pearce; J Crane; P A Silva
Journal:  Eur Respir J       Date:  1997-01       Impact factor: 16.671

5.  Evidence-based health policy--lessons from the Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

6.  Increase of asthma in adults in northern Finland?--a report from the FinEsS study.

Authors:  J T Kotaniemi; B Lundbäck; M M Nieminen; A R Sovijärvi; L A Laitinen
Journal:  Allergy       Date:  2001-02       Impact factor: 13.146

7.  Use of a postal questionnaire to estimate the likely under-diagnosis of asthma-like illness in adults.

Authors:  P Frank; S Ferry; T Moorhead; P Hannaford
Journal:  Br J Gen Pract       Date:  1996-05       Impact factor: 5.386

8.  Recent trends in physician diagnosed COPD in women and men in the UK.

Authors:  J B Soriano; W C Maier; P Egger; G Visick; B Thakrar; J Sykes; N B Pride
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

9.  Declining incidence of episodes of asthma: a study of trends in new episodes presenting to general practitioners in the period 1989-98.

Authors:  D M Fleming; R Sunderland; K W Cross; A M Ross
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

10.  Intergenerational 20 year trends in the prevalence of asthma and hay fever in adults: the Midspan family study surveys of parents and offspring.

Authors:  M N Upton; A McConnachie; C McSharry; C L Hart; G D Smith; C R Gillis; G C Watt
Journal:  BMJ       Date:  2000-07-08
View more
  5 in total

1.  Temporal change in health-related quality of life: a longitudinal study in general practice 1999-2004.

Authors:  Michelle L Hazell; Julie A Morris; Mary F Linehan; Timothy L Frank
Journal:  Br J Gen Pract       Date:  2009-11       Impact factor: 5.386

2.  Long term prognosis in preschool children with wheeze: longitudinal postal questionnaire study 1993-2004.

Authors:  Peter I Frank; Julie A Morris; Michelle L Hazell; Mary F Linehan; Timothy L Frank
Journal:  BMJ       Date:  2008-06-16

3.  Smoking, respiratory symptoms and likely asthma in young people: evidence from postal questionnaire surveys in the Wythenshawe Community Asthma Project (WYCAP).

Authors:  Peter Frank; Julie Morris; Michelle Hazell; Mary Linehan; Timothy Frank
Journal:  BMC Pulm Med       Date:  2006-05-22       Impact factor: 3.317

4.  Models for estimating and projecting global, regional and national prevalence and disease burden of asthma: a systematic review.

Authors:  Mohammad Romel Bhuia; Md Atiqul Islam; Bright I Nwaru; Christopher J Weir; Aziz Sheikh
Journal:  J Glob Health       Date:  2020-12-30       Impact factor: 4.413

5.  Prevalence of respiratory symptoms at two time points in a population of children in Manchester--a cohort study.

Authors:  Mary F Linehan; Robert M Niven; David N Baxter; Julie A Morris; Timothy L Frank
Journal:  BMJ Open       Date:  2012-10-11       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.